A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction

Summary

The purpose of this study is to evaluate the safety, pharmacokinetics, and effect on cardiac function of intravenous APD418 in adult participants with heart failure with reduced ejection fraction (HFrEF).

Timeline

Start

2021-12-28

Primary completion

2022-09-19

Completion

2022-09-19

Outcome

Outcome not reported

Stopped (Business): “Business decision”

Drugs

Indications